British Journal of Haematology

Paravertebral extramedullary haemopoiesis associated with pyruvate kinase deficiency
pp. 275-275(1)
Authors: Hipkins, Rupert; Thompson, Joyce; Naidoo, Prabha; Bishay, Ehab; Djearaman, Madava; Pratt, Guy

Toxoplasma gondii in the bone marrow after pancreas-kidney transplantation
pp. 276-276(1)
Authors: Seguro, Fernanda S.; Assis, Reijane A.; Silveira, Paulo A. A.; Bezerra, Alanna M. P. S.

Testing children for inherited thrombophilia: more questions than answers
pp. 277-288(12)
Authors: Raffini, Leslie; Thornburg, Courtney

Genetic risk factors of thrombosis in the antiphospholipid syndrome
pp. 289-296(8)
Authors: Castro-Marrero, Jesús; Balada, Eva; Vilardell-Tarrés, Miquel; Ordi-Ros, Josep

Preclinical activity of 8-chloroadenosine with mantle cell lymphoma: roles of energy depletion and inhibition of DNA and RNA synthesis
pp. 297-307(11)
Authors: Dennison, Jennifer B.; Balakrishnan, Kumudha; Gandhi, Varsha

Interleukin-4 distinctively modifies responses of germinal centre-like and activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapy
pp. 308-318(11)
Authors: Sarosiek, Kristopher A.; Nechushtan, Hovav; Lu, Xiaoqing; Rosenblatt, Joseph D.; Lossos, Izidore S.

Anti-myeloma activity of the novel 2-aminothienopyrimidine Hsp90 inhibitor NVP-BEP800
pp. 319-327(9)
Authors: Stühmer, Thorsten; Chatterjee, Manik; Grella, Evelyn; Seggewiss, Ruth; Langer, Christian; Müller, Sabine; Schoepfer, Joseph; Garcia-Echeverria, Carlos; Quadt, Cornelia; Jensen, Michael R.; Einsele, Hermann; Bargou, Ralf C.

Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells
pp. 328-338(11)
Authors: Arseneau, Jean-René; Laflamme, Mark; Lewis, Stephen M.; Maïcas, Emmanuel; Ouellette, Rodney J.

Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia
pp. 339-346(8)
Authors: Matos, Daniel M.; Ismael, Sebastião J.; Scrideli, Carlos A.; de Oliveira, Fábio M.; Rego, Eduardo M.; Falcão, Roberto P.

TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3
pp. 347-351(5)
Authors: Shaughnessy, John D.; Zhou, Yiming; Haessler, Jeff; van Rhee, Frits; Anaissie, Elias; Nair, Bijay; Waheed, Sarah; Alsayed, Yazan; Epstein, Joshua; Crowley, John; Barlogie, Bart

Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients
pp. 352-359(8)
Authors: Campbell, Andrew; Minniti, Caterina P.; Nouraie, Mehdi; Arteta, Manuel; Rana, Sohail; Onyekwere, Onyinye; Sable, Craig; Ensing, Gregory; Dham, Niti; Luchtman-Jones, Lori; Kato, Gregory J.; Gladwin, Mark T.; Castro, Oswaldo L.; Gordeuk, Victor R.

Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients
pp. 360-370(11)
Authors: Eyrich, Matthias; Wiegering, Verena; Lim, Annick; Schrauder, Andre; Winkler, Beate; Schlegel, Paul G.

Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia
pp. 371-378(8)
Authors: Locatelli, Franco; Testi, Anna M.; Bernardo, Maria Ester; Rizzari, Carmelo; Bertaina, Alice; Merli, Pietro; Pession, Andrea; Giraldi, Eugenia; Parasole, Rosanna; Barberi, Walter; Zecca, Marco

A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases
pp. 379-385(7)
Authors: Létocart, Emilie; Le Gac, Gérald; Majore, Silvia; Ka, Chandran; Radio, Francesca C.; Gourlaouen, Isabelle; De Bernardo, Carmelilia; Férec, Claude; Grammatico, Paola

Genomic mutations associated with mild and severe deficiencies of transcobalamin I (haptocorrin) that cause mildly and severely low serum cobalamin levels
pp. 386-391(6)
Authors: Carmel, Ralph; Parker, James; Kelman, Zvi

Association studies of erythoid α-spectrin at the tetramerization site
pp. 392-395(4)
Authors: Lam, Vinh Q.; Antoniou, Chloe; Rolius, Ramunas; Fung, Leslie W.-M.

Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro
pp. 396-398(3)
Authors: Amrein, Lilian; Panasci, Lawrence; Gibson, Spencer B.; Johnston, James B.; Soulières, Denis; Aloyz, Raquel

MicroRNA expression in chronic lymphocytic leukaemia
pp. 398-402(5)
Authors: Lawrie, Charles H.; Ballabio, Erica; Dyar, Oliver-James; Jones, Margaret; Ventura, Roland; Chi, Jianxiang; Tramonti, Daniela; Gooding, Sarah; Boultwood, Jacqueline; Wainscoat, James S.; Hatton, Christian S.R.; Schuh, Anna

Biological markers and prognostic scoring systems in chronic lymphocytic leukaemia
pp. 402-404(3)
Authors: Orlandi, Ester M.; Pascutto, Cristiana; Zibellini, Silvia; Pochintesta, Lara; Vanelli, Laura

Elevation of clonal serum free light chains in patients with HIV-negative primary effusion lymphoma (PEL) and PEL-like lymphoma
pp. 405-408(4)
Authors: De Filippi, Rosaria; Iaccarino, Giancarla; Frigeri, Ferdinando; Di Francia, Raffaele; Crisci, Stefania; Capobianco, Gaetana; Arcamone, Manuela; Becchimanzi, Cristina; Amoroso, Barbara; De Chiara, Annarosaria; Corazzelli, Gaetano; Pinto, Antonio

Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy
pp. 408-410(3)
Authors: Intermesoli, Tamara; Shamash, Jonathan; Rohatiner, Ama; Wilson, Andrew; Lister, Andrew; Montoto, Silvia

Corrigendum
pp. 411-411(1)